Revenio Group Oyj - Major shareholder announcements

Revenio Group Corporation: Notice pursuant to section 5, chapter 9 of the Securities Market Act

Revenio Group Corporation, Stock Exchange Release, May 22, 2015 at 12:00

NOTICE PURSUANT TO SECTION 5, CHAPTER 9 OF THE SECURITIES MARKET ACT

Revenio Group Corporation has today received a notification of change in
holdings in accordance with Chapter 9, Section 5 of the Securities Markets Act
that Evli Pankki Oyj's share of the total number of shares and voting rights in
Revenio Group Corporation has increased to more than one twentieth (1/20).

Evli Pankki Oyj now holds 445,786 shares in Revenio Group Corporation, which is
5.62 percent of the company's shares and voting rights.

The total number of Revenio Group Corporation's shares recorded in the trade
register is 7,933,078.

Olli-Pekka Salovaara
President and CEO

For further information, please contact:
President & CEO Olli-Pekka Salovaara, tel. +358 40 567 5520
olli-pekka.salovaara@revenio.fi
www.revenio.fi

DISTRIBUTION:
NASDAQ OMX Helsinki
Financial Supervisory Authority (FIN-FSA)
Principal media
www.revenio.fi

The Revenio Group in brief

Revenio is a Finnish health tech group whose core business is in tonometers. The
Revenio Health Tech segment comprises the business operations of Icare Finland
Oy, Revenio Research Oy and Oscare Medical Oy, which specializes in osteoporosis
screening and monitoring. The common denominators of Revenio's business
operations include screening, follow-up and the global need to make cost savings
in health care via preventive measures. Revenio seeks vigorous growth in health
technology, both organically and through acquisitions and mergers. Revenio aims
at developing even more efficient and easily adopted methods for the early-stage
detection of diseases with significance for public health. The focus of
Revenio's screening technology lies on the early detection of glaucoma,
osteoporosis, skin cancer and asthma, and the monitoring of these during the
treatment process.

In 2014, the Revenio Group's net sales totaled MEUR 16.0, with its operating
profit (EBIT) from continuing operations standing at 27.5%. The Revenio Group
Corporation is listed on NASDAQ OMX Helsinki.

[HUG#1923451]